ENZYME-INHIBITORY AUTOANTIBODIES TO PYRUVATE-DEHYDROGENASE COMPLEX INPRIMARY BILIARY-CIRRHOSIS - APPLICATIONS OF A SEMIAUTOMATED ASSAY

Citation
Kl. Teoh et al., ENZYME-INHIBITORY AUTOANTIBODIES TO PYRUVATE-DEHYDROGENASE COMPLEX INPRIMARY BILIARY-CIRRHOSIS - APPLICATIONS OF A SEMIAUTOMATED ASSAY, Hepatology, 20(5), 1994, pp. 1220-1224
Citations number
27
Categorie Soggetti
Gastroenterology & Hepatology
Journal title
ISSN journal
02709139
Volume
20
Issue
5
Year of publication
1994
Pages
1220 - 1224
Database
ISI
SICI code
0270-9139(1994)20:5<1220:EATPCI>2.0.ZU;2-9
Abstract
Sera from patients with primary biliary cirrhosis inhibit the activity of the mitochondrial pyruvate dehydrogenase complex. We utilized this effect to develop a simple, miniaturized, semiautomated spectrophotom etric assay as a diagnostic aid. The sera studied were from 71 patient s with primary biliary cirrhosis and 62 other subjects. The assays inc luded enzyme inhibition, immunofluorescence on HEp-2 cells, enzyme-lin ked immunosorbent assay using recombinant pyruvate dehydrogenase compl ex-E2 and immunoblotting on bovine heart mitochondria. With the 71 pri mary biliary cirrhosis sera, on which M2 antibody was detected by immu nofluorescence in 64 (90%), antibodies against pyruvate dehydrogenase complex were detected in 53 (83%) by means of enzyme inhibition, in 57 (89%) by means of enzyme-linked immunosorbent assay and in 60 (94%) b y means of immunoblotting. Of the 64 sera positive by immunofluorescen ce, 60 reacted with pyruvate dehydrogenase complex-E2 on immunoblottin g, and the miniaturized enzyme inhibition assay was positive in 53 of these. The enzyme inhibition assay and enzyme-linked immunosorbent ass ay were calibrated to give a specificity of 100%. At this level, the s ensitivities for detection of pyruvate dehydrogenase complex antibody were 83% and 87%, respectively. We found no significant changes in lev els of reactivity with the enzyme inhibition assay or enzyme-linked im munosorbent assay according to disease stage. Treatment with cyclospor ine was accompanied by a significant decrease in levels of antibody to pyruvate dehydrogenase complex-E2 that matched improved indexes of bi ochemical liver function. The semiautomated enzyme inhibition assay as described provides an additional diagnostic procedure in pyruvate deh ydrogenase complex; this type of assay involving specific enzyme inhib ition could also be generically applied to any autoantibody antigen sy stem.